Abstract
The use of immunotherapy to treat cancer patients can induce immune-related adverse events (irAEs) caused by non-specific activation of the immune system. Patient’s sex can influence adaptive immunity and, in turn, irAEs incidence, type and severity. We are undertaking a multicenter observational prospective study to investigate irAEs incidence, and female (F)/male (M) inequalities linked to sex (genetic and biological characteristics) and gender (psycho-social and behavioural determinants).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
